NASH PASS®: Improving Patient Enrollment and Streamlining Site Selection for NAFLD and NASH Clinical Trials

About this Fact Sheet

ProSciento’s NASH PASS® is a science-driven clinical research and patient registry platform, leveraging more than a decade of NASH therapeutic and operational expertise, and designed to overcome enrollment challenges inherent in NASH clinical trials. The platform streamlines and substantially improves site selection, patient access, and enrollment for NASH clinical trials. It is also an important, evolving tool to enhance the scientific knowledge of NAFLD and NASH disease progression and the development of novel biomarkers for clinical research.